Interstitial lung disease (ILD) Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 28
SKU : PH5053
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
Which region controls the Global Interstitial lung disease (ILD) Market during 2023-2030 ?
North America region Controls the Global Interstitial lung disease (ILD) Market.
Who are the key players in Global Interstitial lung disease (ILD) Market ?
Major players are Novartis Pharmaceuticals Corporation, Genentech Inc, Roche Laboratories Inc, Teva Pharmaceuticals USA Inc, Prometheus Laboratories Inc, Amneal Pharmaceuticals LLC, Boehringer Ingelheim Pharmaceuticals Inc, Amgen In and Horizon Pharma USA Inc.